Biomarkers and Parkinson's disease

By Michell A. W.   Lewis S. J. G.   Foltynie T.   Barker R. A.  

Brain, Vol. 127, Iss. 8, 2004-08 ,pp. : 1693-1705

Oxford University Press

Access to resources Recommend Favorite

Gene-expression profiling in Parkinson’s disease: discovery of valid biomarkers, molecular targets and biochemical pathways

By Papapetropoulos Spiridon   McCorquodale Donald  

Future Neurology, Vol. 2, Iss. 1, 2007-01 ,pp. : 29-38

Future Medicine

Access to resources Recommend Favorite

Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson’s disease subjects

By Maarouf Chera L   Beach Thomas G   Adler Charles H   Shill Holly A   Sabbagh Marwan N   Wu Terence   Walker Douglas G   Kokjohn Tyler A   Roher Alex E   PD Consortium Arizona  

Neurological Research, Vol. 34, Iss. 7, 2012-09 ,pp. : 669-676

Maney Publishing

Access to resources Recommend Favorite

Editorial (Application of a Multidisciplinary Approach to Alzheimer's Disease to Develop Novel Drug Targets by Integrating Biomarkers, Imaging, Genetic and Molecular Strategies)

By  

Current Alzheimer Research, Vol. 8, Iss. 1, 2011-01 ,pp. : 1-3

Bentham Science Publishers

Access to resources Recommend Favorite

Oxidative stress and inflammation biomarkers in the blood of patients with Huntington’s disease

By Sánchez-López Fernando   Tasset Inmaculada   Agüera Eduardo   Feijóo Montserrat   Fernández-Bolaños Ricardo   Sánchez Francisco M   Ruiz María C   Cruz Antonio H   Gascón Félix   Túnez Isaac  

Neurological Research, Vol. 34, Iss. 7, 2012-09 ,pp. : 721-724

Maney Publishing

Access to resources Recommend Favorite